MedTrace Logo

Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis

NCT06652464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-03-07

No results posted yet for this study

Summary

Specialized pro-resolving mediators (SPMs), which are typically thought to be formed via consecutive steps of oxidation of polyenoic fatty acids, have been shown to suppress inflammation and promote timely resolution of inflammation. They are mainly divided into four categories: lipoxins, resolvins, protectins, and maresins. The study will compare Maresin-1 and Resolvin-D1 levels in ulcerative colitis patients with those in the control group.

Conditions

  • Disease Activity
  • Remission of Ulcerative Colitis
  • Ulcerative Colitis Flare

Sponsors & Collaborators

  • Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

    lead OTHER

Principal Investigators

  • selim demirci, medical doctor · Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-11-01
Completion
2024-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06652464 on ClinicalTrials.gov